Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.